卫光生物
(002880)
| 流通市值：58.24亿 | | | 总市值：58.24亿 |
| 流通股本：2.27亿 | | | 总股本：2.27亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 76,625,513.01 | 369,814,870.7 | 79,599,872.52 | 135,985,076.18 |
| 应收票据及应收账款 | 390,010,702.06 | 361,111,666.61 | 262,601,652.9 | 261,348,414.97 |
| 其中：应收票据 | 169,550 | 57,733,725.9 | 87,137,281.56 | 91,304,952.99 |
| 应收账款 | 389,841,152.06 | 303,377,940.71 | 175,464,371.34 | 170,043,461.98 |
| 应收款项融资 | 15,245,477.54 | 49,456,265 | - | - |
| 预付款项 | 4,221,989.31 | 2,483,578.39 | 6,394,700.16 | 4,122,965.71 |
| 其他应收款合计 | 25,819,756.36 | 17,837,870.4 | 24,112,590.38 | 23,769,837.77 |
| 存货 | 951,050,626.25 | 882,726,616.4 | 966,635,488.07 | 898,157,234.32 |
| 其他流动资产 | 4,955,999.43 | 2,990,570.79 | 6,012,759.57 | 4,427,309.94 |
| 流动资产合计 | 1,467,930,063.96 | 1,686,421,438.29 | 1,345,357,063.6 | 1,327,810,838.89 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 96,039,943.55 | 79,539,943.55 | 77,669,283.18 | 77,669,283.18 |
| 投资性房地产 | 844,249,989.09 | 856,772,330.51 | 869,342,520.53 | 776,604,429.63 |
| 固定资产 | 569,936,696.78 | 584,703,414.14 | 592,565,968.56 | 677,025,810.27 |
| 在建工程 | 39,075,274.52 | 20,873,312.81 | 13,207,428.73 | 10,082,725.05 |
| 使用权资产 | 13,456,123.68 | 13,844,879.34 | 14,087,151.36 | 14,329,423.38 |
| 无形资产 | 148,634,411.58 | 150,765,525.9 | 152,383,603.43 | 130,956,569.64 |
| 开发支出 | 41,873,780.77 | 40,843,780.77 | 35,763,539.91 | 28,701,834.6 |
| 商誉 | 19,230,057.19 | 19,230,057.19 | 19,230,057.19 | 19,230,057.19 |
| 长期待摊费用 | 11,093,325.5 | 11,817,124.49 | 9,499,354.24 | 9,553,214.62 |
| 递延所得税资产 | 20,736,472.89 | 22,718,906.79 | 10,465,681.38 | 10,079,255.62 |
| 其他非流动资产 | 395,050,220.38 | 252,526,174.94 | 254,524,692.07 | 260,413,085.29 |
| 非流动资产合计 | 2,199,376,295.93 | 2,053,635,450.43 | 2,048,739,280.58 | 2,014,645,688.47 |
| 资产总计 | 3,667,306,359.89 | 3,740,056,888.72 | 3,394,096,344.18 | 3,342,456,527.36 |
| 流动负债: | | | | |
| 短期借款 | 269,504,846.26 | 283,002,277.52 | 126,381,320.36 | 100,000,000 |
| 应付票据及应付账款 | 101,744,559.25 | 112,824,747.95 | 134,678,141.59 | 129,508,279.22 |
| 其中：应付票据 | 1,892,000 | 12,444,064.02 | 10,927,064.02 | - |
| 应付账款 | 99,852,559.25 | 100,380,683.93 | 123,751,077.57 | 129,508,279.22 |
| 预收款项 | 250,921.19 | 204,414.44 | 104,852.5 | 92,705 |
| 合同负债 | 22,369,993.88 | 21,839,318.78 | 7,633,158.46 | 769,572.82 |
| 应付职工薪酬 | 51,257,830.79 | 95,657,733.53 | 79,521,146.25 | 70,430,322.26 |
| 应交税费 | 24,285,301.28 | 35,672,304.59 | 20,359,250.99 | 21,960,799.55 |
| 其他应付款合计 | 104,258,534.08 | 113,443,145.12 | 43,288,606.59 | 84,135,101.37 |
| 应付股利 | - | - | - | 45,360,000 |
| 一年内到期的非流动负债 | 47,691,403.14 | 47,725,853.14 | 48,510,038.64 | 48,400,498.93 |
| 其他流动负债 | 38,120.82 | 1,565,650.43 | 330,881.54 | 23,087.18 |
| 流动负债合计 | 621,401,510.69 | 711,935,445.5 | 460,807,396.92 | 455,320,366.33 |
| 非流动负债: | | | | |
| 长期借款 | 481,338,954.1 | 493,220,869.04 | 495,642,292.42 | 506,502,651.42 |
| 租赁负债 | 15,086,958.44 | 14,712,698 | 15,932,675.17 | 15,760,074.91 |
| 递延收益 | 56,956,962.96 | 58,503,079.95 | 47,878,196.87 | 41,070,520.14 |
| 递延所得税负债 | 11,033,210.77 | 10,965,993.78 | 11,090,156.41 | 11,300,107.62 |
| 其他非流动负债 | 5,577,197.82 | 5,577,197.82 | 6,052,844.11 | 6,052,844.11 |
| 非流动负债合计 | 569,993,284.09 | 582,979,838.59 | 576,596,164.98 | 580,686,198.2 |
| 负债合计 | 1,191,394,794.78 | 1,294,915,284.09 | 1,037,403,561.9 | 1,036,006,564.53 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 226,800,000 | 226,800,000 | 226,800,000 | 226,800,000 |
| 资本公积 | 563,493,192.55 | 563,493,192.55 | 563,493,192.55 | 563,493,192.55 |
| 盈余公积 | 219,036,677.65 | 219,036,677.65 | 194,612,071.44 | 194,612,071.44 |
| 未分配利润 | 1,434,039,174.83 | 1,403,056,200.79 | 1,339,020,604.4 | 1,288,806,412.62 |
| 归属于母公司股东权益合计 | 2,443,369,045.03 | 2,412,386,070.99 | 2,323,925,868.39 | 2,273,711,676.61 |
| 少数股东权益 | 32,542,520.08 | 32,755,533.64 | 32,766,913.89 | 32,738,286.22 |
| 股东权益合计 | 2,475,911,565.11 | 2,445,141,604.63 | 2,356,692,782.28 | 2,306,449,962.83 |
| 负债和股东权益合计 | 3,667,306,359.89 | 3,740,056,888.72 | 3,394,096,344.18 | 3,342,456,527.36 |
| 公告日期 | 2026-04-27 | 2026-04-27 | 2025-10-31 | 2025-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |